SCV

Sands Capital Ventures Portfolio holdings

AUM $508M
This Quarter Return
-24.97%
1 Year Return
+48.12%
3 Year Return
+324.3%
5 Year Return
–
10 Year Return
–
AUM
$479M
AUM Growth
+$479M
Cap. Flow
+$24.2M
Cap. Flow %
5.05%
Top 10 Hldgs %
93.53%
Holding
18
New
2
Increased
–
Reduced
–
Closed
–

Top Buys

1
CINC
CinCor Pharma, Inc. Common Stock
CINC
$16.7M
2
OLK
Olink Holding AB (publ) American Depositary Shares
OLK
$7.52M

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 32.9%
2 Technology 28.56%
3 Financials 14.74%
4 Consumer Discretionary 14.73%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
PATH icon
1
UiPath
PATH
$5.95B
$82.3M 17.19%
3,811,779
– –
NU icon
2
Nu Holdings
NU
$71.5B
$70.5M 14.74%
9,136,835
– –
DASH icon
3
DoorDash
DASH
$105B
$70.5M 14.73%
601,454
– –
DICE
4
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
$60.2M 12.59%
3,148,970
– –
SNOW icon
5
Snowflake
SNOW
$79.6B
$49.2M 10.27%
214,621
– –
KRTX
6
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$34M 7.1%
267,895
– –
CINC
7
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
$16.7M 3.48%
+950,000
New +$16.7M
ABOS icon
8
Acumen Pharmaceuticals
ABOS
$82.4M
$13.4M 2.79%
3,417,075
– –
OLK
9
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
$7.52M 1.57%
+425,514
New +$7.52M
MASS icon
10
908 Devices
MASS
$226M
$6.21M 1.3%
326,427
– –
IOT icon
11
Samsara
IOT
$20.6B
$5.22M 1.09%
326,000
– –
TSHA icon
12
Taysha Gene Therapies
TSHA
$797M
$4.73M 0.99%
724,873
– –
TARS icon
13
Tarsus Pharmaceuticals
TARS
$2.47B
$4.37M 0.91%
260,000
– –
RGEN icon
14
Repligen
RGEN
$6.88B
$4.24M 0.89%
22,544
– –
CADL icon
15
Candel Therapeutics
CADL
$318M
$4.13M 0.86%
811,737
– –
SPRB
16
DELISTED
Spruce Biosciences, Inc. Common Stock
SPRB
$1.58M 0.33%
787,007
– –
ABSI icon
17
Absci
ABSI
$357M
$487K 0.1%
57,804
– –